NanoString Technologies Inc (NanoString) develops solutions and life science tools for translational research and molecular diagnostics. The company's product pipeline includes ncounter, geomx, atomx and cosmx. Its ncounter is an automated, multi-application, digital detection and counting system which directly profiles hundreds of molecules simultaneously, using optical barcoding chemistry. NanoString ncounter platform is based on automated instruments that prepare and analyze biological samples using reagents. The company focused research on various fields such as biopharma, oncology, spatial multiomics, cell and gene therapy solutions, infectious disease, neuroscience, COVID-19 and immunology, among others. It has an operational presence in the Netherlands, Hong Kong, the UK and Singapore. NanoString is headquartered in Seattle, Washington, the US.
Headquarters
United States of America
Address
530 Fairview Avenue North, Seattle, Washington, 98109
Website
www.nanostring.com
Telephone
1 206 3786266
No of Employees
703
Industry
Medical Equipment
Ticker Symbol & Exchange
NSTGQ (OTC)
Revenue (2021)
$127.3M
-12.3%
(2021 vs 2020)
EPS
XYZ
Net Income (2021)
XYZ
-38.4%
(2021 vs 2020)
Market Cap*
$8.3M
Net Profit Margin (2021)
XYZ
-57.8%
(2021 vs 2020)
* As of and is in US$
NanoString Technologies Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Geomx (Digital Spatial Profiler) | Geomx |
| Geomx (Assays) | Atomx |
| Atomx (Spatial Informatics Platform) | Ncounter |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Corporate Changes/Expansions | In October, the company along with A*STAR’s Genome Institute of Singapore and Next Level Genomics announced the establishment of a joint laboratory in Singapore. |
| 2023 | Contracts/Agreements | In September, the company expanded its partnership with Macrogen, Propath UK and Sirona Dx to provide new access to customers for CosMx SMI technology for translational drug development. |
| 2023 | Contracts/Agreements | In June, the company along with Acrobat Genomics and the Illumina Accelerator entered into a collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx digital spatial profiling (DSP) technology. |
Competitor Comparison
| Key Parameters | NanoString Technologies Inc | Thermo Fisher Scientific Inc | Agilent Technologies Inc | Illumina Inc | Bio-Rad Laboratories Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Seattle | Waltham | Santa Clara | San Diego | Hercules |
| State/Province | Washington | Massachusetts | California | California | California |
| No. of Employees | 703 | 122,000 | 17,700 | 10,590 | 8,030 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| William D. Young | Chairman | Executive Board | 2010 | 78 |
| Brad Gray | Director; Chief Executive Officer; President | Executive Board | 2010 | 46 |
| K. Thomas Bailey | Chief Financial Officer | Senior Management | 2018 | 54 |
| Joseph M. Beechem | Chief Scientific Officer; Senior Vice President - Research and Development | Senior Management | 2012 | 65 |
| David W. Ghesquiere | Senior Vice President - Corporate and Business Development | Senior Management | 2013 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward